We   handle   the   preparation   of   all   types   of   registration
applications  for  new  pharmaceutical  products  (such  as  new
chemical entities, biological products, and medical devices) and
additional  new  indications.  We also handle the submission of
clinical  trial  applications  for   new   pharmaceutical   products
(including   those   under   global   multi-center   development),
applications  for  post-clinical  trial  productions and marketing
authorizations, and so on. In addition, we offer a broad range of
professional   consultancy   services   for   acquiring   local   and
foreign  patents  including  the  so-called  drug  Administrative
Protection  of  various  products, based on diversified strategies
for  the  establishment  and  protection  of  intellectual property
rights.   Such   activities   are   carried   out  in  compliance  with
drug  administration  laws  in  China,  and  regulations  for drug
registration   issued   by   the   Chinese   State   Food   and  Drug
Administration (SFDA).